AIM

#3998
AIM ImmunoTech Inc.
0.9076
-8.77%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
0.8747
0.9252
Jahresspanne
0.7653
20.3500
Tagesänderung
-8.77%
Monatliche Änderung
-24.99%
6 month change
-64.12%
Jahresänderung
-89.32%
Vorheriger Schlusskurs
0.9948
Open
0.8851
Bid
Ask
Low
0.8747
High
0.9252
Volumen
20
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.9 M
  • Employee 23
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Nachrichten